yes, alnby, the impairment loss taken above the line is one of the factors that accounted for the "20% earnings understatement" that I alluded to earlier.
Then there are also:
- $156k of expenses relating to the executive share plan (pcp: $11k),
- $220k expense for equity-settled, share-based payments (pcp: $66k), and
- $128k of R&D expenses (pcp: $23k).
While there are a few offsets to these directly-expensed imposts (when more aggressive financial directors might have accounted for them in a less punitive fashion), the net effect I estimate to have been close to a negative $1.0m delta on JH14 Pre-tax Profit.
This result is prudential buffer and padding.
It's the way all self-respecting shareholders should want it.
- Forums
- ASX - By Stock
- dividend
yes, alnby, the impairment loss taken above the line is one of...
Featured News
Add KOV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$10.20 |
Change
-0.020(0.20%) |
Mkt cap ! $119.8M |
Open | High | Low | Value | Volume |
$10.35 | $10.35 | $9.96 | $146.8K | 14.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 399 | $10.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.40 | 4754 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 399 | 10.200 |
1 | 201 | 9.960 |
1 | 2025 | 9.900 |
1 | 510 | 9.870 |
1 | 1015 | 9.840 |
Price($) | Vol. | No. |
---|---|---|
10.400 | 4754 | 1 |
10.500 | 8951 | 3 |
10.850 | 500 | 1 |
11.000 | 961 | 1 |
11.340 | 18 | 1 |
Last trade - 15.37pm 04/10/2024 (20 minute delay) ? |
Featured News
KOV (ASX) Chart |